Breaking News Instant updates and real-time market news.

ARA

American Renal Associates

$18.10

0.52 (2.96%)

, DVA

DaVita

$62.66

0.66 (1.06%)

07:51
10/13/16
10/13
07:51
10/13/16
07:51

Price targets cut on dialysis stocks at SunTrust

SunTrust analyst David MacDonald lowered his price targets on dialysis stocks, citing CMS' recent request for information and resulting payor risk and lower assumed multiples. The analyst cut his price target on American Renal Associates (ARA) to $24 from $34, on DaVita (DVA) to $66 from $80 and on Fresenius Medical (FMS) to $48 from $54. He maintains Buy ratings on American Renal and Fresenius but said he does not expect the stocks to rise significantly until the CMS matter is resolved. MacDonald keeps a Hold rating on DaVita.

ARA

American Renal Associates

$18.10

0.52 (2.96%)

DVA

DaVita

$62.66

0.66 (1.06%)

FMS

Fresenius Medical

$41.26

-0.11 (-0.27%)

  • 02

    Nov

  • 06

    Nov

ARA American Renal Associates
$18.10

0.52 (2.96%)

05/16/16
05/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alaska Air (ALK) reinstated with an Outperform at Cowen as the firm believes the shares have been unfairly punished over the past quarter and noted their April unit revenue results exceeded expectations. 2. Microsoft (MSFT) initiated with a Hold at Canaccord citing risk-reward is balanced near-term. 3. lululemon (LULU) reinstated with an Underperform at BofA/Merril by analyst Rafe Jadrosich, who said he sees downside to street estimates. The analyst has a lower sales and margin outlook due to intensifying competition and ongoing investments to support international expansion. 4. American Renal Associations (ARA) initiated with a Buy at SunTrust, an Outperform at Wells Fargo, an Overweight at Barclays, and a Neutral at Goldman. MGM Growth (MGP) initiated with a Buy at BofA/Merrill, Deutsche Bank and SunTrust. It was also initiated with a Neutral at Citi, and an Overweight at JPMorgan and Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/16
WELS
05/16/16
INITIATION
WELS
Outperform
American Renal Associates initiated with an Outperform at Wells Fargo
Wells Fargo analyst Gary Lieberman started American Renal Associates Holdings with an Outperform rating and $30-$34 price target range.
05/16/16
RHCO
05/16/16
INITIATION
Target $34
RHCO
Buy
American Renal Associates initiated with a Buy at SunTrust
Target $34.
05/16/16
GSCO
05/16/16
INITIATION
Target $30
GSCO
Neutral
American Renal Associates initiated with a Neutral at Goldman
Goldman Sachs analyst Matthew Borsch started American Renal Associates Holdings with a Neutral rating and $30 price target.
DVA DaVita
$62.66

0.66 (1.06%)

09/06/16
BOFA
09/06/16
DOWNGRADE
BOFA
Neutral
DaVita downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded DaVita (DVA) to Neutral and lowered its price target to $70 saying growth rates are likely to remain muted. The firm's analyst said poor performance at HCP, Inc (HCP) is unlikely to improve in 2017 and tail risk scenarios on a CMS decision could be bigger than expected on the dialysis business.
09/06/16
09/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) downgraded to Hold from Buy at Jefferies with analyst Brian Abrahams saying his thesis has mostly played out and that shares of Gilead Sciences (GILD) offer greater upside potential. 2. Dollar General (DG) downgraded to Neutral from Buy at Goldman with analyst Stephen Tanal saying same-store-sales have slowed and expects a modest deceleration in earnings growth and further competitive pressures. 3. comScore (SCOR) downgraded to Neutral from Buy at SunTrust with analyst Matthew Thornton saying that consensus 2017 estimates for the company are too high following its August 10 update. 4. Verifone (PAY) downgraded to Hold from Buy at Argus. 5. DaVita (DVA) downgraded to Neutral from Buy at BofA/Merrill with the firm saying growth rates are likely to remain muted. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
09/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson Controls (JCI) initiated with a Sector Perform at RBC Capital with analyst Deane Dray saying he thinks that the company's synergies from its merger can beat expectations, but the analyst says that the stock is already "reflecting optimism." 2. DaVita (DVA) initiated with a Neutral at Citi. 3. Hershey (HSY) reinstated with a Neutral at JPMorgan. 4. Dollar Tree (DLTR) coverage assumed with a Conviction Buy at Goldman. 5. Lockheed Martin (LMT) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
RAJA
09/20/16
UPGRADE
Target $75
RAJA
Outperform
DaVita upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst John Ransom upgraded DaVita to Outperform and established a $75 price target. saying shares have corrected by approximately 18% following Q2 results and concerns about ACA exchange exposure. The analyst views valuation as attractive and thinks ACA exposure is a bit less than previous estimates. Further, investor expectations for DVA Medical Group are low and represent less than 10% EBIT, Ransom wrote.
FMS Fresenius Medical
$41.26

-0.11 (-0.27%)

05/09/16
BERN
05/09/16
NO CHANGE
BERN
Teva, Fresenius Medical added to recommended portfolio at Bernstein
Bernstein added Teva (TEVA) and Fresenius Medical (FMS) to its recommended portfolio of healthcare stocks. The firm says that Fresenius is not exposed to the pricing pressures affecting the sector, while Teva will allow investors to take advantage of the strong value opportunity within the pharma sector. In conjunction with its recommendation of Teva and Fresenius, Bernstein upgraded the European healthcare sector two notches, to Overweight from Underweight. The firm says that the downturn in the sector on drug pricing pressures has been overdone. According to the firm, drug prices will be pressured, but pharma stocks are currently reflecting no growth beyond 2020. Bernstein believes that outlook is overly pessimistic.
09/06/16
SBSH
09/06/16
INITIATION
SBSH
Buy
Fresenius Medical initiated with a Buy at Citi
Price target EUR 98.
09/06/16
SBSH
09/06/16
INITIATION
Target $71
SBSH
Neutral
DaVita initiated with a Neutral at Citi
Citi analyst Patrick Wood started DaVita Healthcare Partners (DVA) with a Neutral rating and $71 price target. The analyst sees limited upside to consensus estimates and prefers Fresenius Medical Care (FMS) at current share levels.
07/08/16
JEFF
07/08/16
UPGRADE
JEFF
Hold
Fresenius Medical upgraded to Hold from Underperform at Jefferies
Jefferies analyst Chris Cooper upgraded Fresenius Medical to Hold with a EUR 81 price target.

TODAY'S FREE FLY STORIES

13:05
01/23/18
01/23
13:05
01/23/18
13:05
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:05
01/23/18
01/23
13:05
01/23/18
13:05
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

OSTK

Overstock.com

$77.40

-0.25 (-0.32%)

13:05
01/23/18
01/23
13:05
01/23/18
13:05
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

13:03
01/23/18
01/23
13:03
01/23/18
13:03
Hot Stocks
Samsung unveils 860 PRO, 860 EVO solid state drives powered by V-NAND »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CREE

Cree

$36.69

0.4 (1.10%)

12:58
01/23/18
01/23
12:58
01/23/18
12:58
Downgrade
Cree rating change  »

Tigress downgrades Cree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CREE

Cree

$36.69

0.4 (1.10%)

12:54
01/23/18
01/23
12:54
01/23/18
12:54
Downgrade
Cree rating change  »

Cree downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PUBGY

Publicis

$17.85

0.03 (0.17%)

12:50
01/23/18
01/23
12:50
01/23/18
12:50
Hot Stocks
Publicis says undergoing 'destabilization attempt,' rejects allegations »

Publicis Groupe said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$61.67

0.42 (0.69%)

12:50
01/23/18
01/23
12:50
01/23/18
12:50
Options
Call buyers in Merck as shares move higher »

Call buyers in Merck as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

12:50
01/23/18
01/23
12:50
01/23/18
12:50
General news
U.S. corporate bond update: the slate is thin with just a couple of issues »

U.S. corporate bond…

BCS

Barclays

$11.68

-0.06 (-0.51%)

12:46
01/23/18
01/23
12:46
01/23/18
12:46
Periodicals
Ex-Barclays banker recorded saying he destroyed key report, Bloomberg says »

Former Barclays top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.29

-0.16 (-0.30%)

12:43
01/23/18
01/23
12:43
01/23/18
12:43
Hot Stocks
Verizon giving 50 shares to employees following tax reform »

Verizon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

CBOE

Cboe Global Markets

$134.56

0.68 (0.51%)

12:42
01/23/18
01/23
12:42
01/23/18
12:42
Hot Stocks
Cboe Global Markets recognized in Hong Kong as approved stock exchange »

Cboe Global Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

RIG

Transocean

$11.68

-0.25 (-2.10%)

12:40
01/23/18
01/23
12:40
01/23/18
12:40
Options
Rolling action in Transocean calls »

Rolling action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$6.30

0.01 (0.16%)

, JPM

JPMorgan

$114.46

0.13 (0.11%)

12:35
01/23/18
01/23
12:35
01/23/18
12:35
Hot Stocks
GoPro falls after Morgan Stanley downgrade cites limited strategic value »

Shares of GoPro (GPRO)…

GPRO

GoPro

$6.30

0.01 (0.16%)

JPM

JPMorgan

$114.46

0.13 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 07

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MET

MetLife

$53.56

-0.29 (-0.54%)

12:31
01/23/18
01/23
12:31
01/23/18
12:31
Hot Stocks
MetLife issues statement on court decision to dismiss appeal in SIFI litigation »

MetLife chairman,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 12

    Jun

CVE

Cenovus Energy

$10.43

0.04 (0.38%)

12:30
01/23/18
01/23
12:30
01/23/18
12:30
Options
Call buyers in Cenovus Energy as shares tick higher »

Call buyers in Cenovus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$135.52

0.31 (0.23%)

12:28
01/23/18
01/23
12:28
01/23/18
12:28
Technical Analysis
Technical Earnings Preview: United Technologies in uptrend before news »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AGN

Allergan

$187.32

-0.83 (-0.44%)

12:25
01/23/18
01/23
12:25
01/23/18
12:25
Options
Allergan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 06

    Feb

  • 16

    Feb

  • 25

    Mar

12:25
01/23/18
01/23
12:25
01/23/18
12:25
Conference/Events
Leerink healthcare services analysts hold an analyst/industry conference call »

Healthcare Services…

VZ

Verizon

$53.23

-0.235 (-0.44%)

12:22
01/23/18
01/23
12:22
01/23/18
12:22
Periodicals
Verizon giving employees 50 shares of restricted stock, CNBC reports »

CNBC's David Faber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

CHFN

Charter Financial

$18.13

-0.12 (-0.66%)

12:21
01/23/18
01/23
12:21
01/23/18
12:21
Hot Stocks
Charter Financial raises quarterly dividend to 8c per share from 5c »

Charter Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$36.96

0.7 (1.93%)

, FOXA

21st Century Fox

$37.31

0.66 (1.80%)

12:20
01/23/18
01/23
12:20
01/23/18
12:20
Hot Stocks
21st Century Fox 'welcomes' part of CMA finding, 'disappointed' about plurality »

21st Century Fox (FOXA)…

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

SKYAY

Sky

$55.97

0.72 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 07

    Feb

$NSD

NASDAQ Market Internals

12:17
01/23/18
01/23
12:17
01/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

, AMZN

Amazon.com

$1,327.31

32.73 (2.53%)

12:16
01/23/18
01/23
12:16
01/23/18
12:16
Hot Stocks
Netflix's 'Mudbound' gets four Oscar noms, Amazon's 'The Big Sick' gets nod »

Films produced by Netflix…

NFLX

Netflix

$227.58

7.12 (3.23%)

AMZN

Amazon.com

$1,327.31

32.73 (2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
01/23/18
01/23
12:16
01/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.